Onconova Therapeutics Inc
NASDAQ:TRAW
Onconova Therapeutics Inc
NASDAQ:TRAW
Price:
2.14
USD
-1.83%
Market Closed
Market Cap:
$17.1m
Income Statement
Earnings Waterfall
Onconova Therapeutics Inc
Onconova Therapeutics Inc
Income Statement
Onconova Therapeutics Inc
Onconova Therapeutics Inc
Currency: USD
| Mar-2024 | Jun-2024 | Sep-2024 | Dec-2024 | Mar-2025 | Jun-2025 | Sep-2025 | ||
|---|---|---|---|---|---|---|---|---|
| Revenue | ||||||||
| Revenue |
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
+0%
|
3
+1 179%
|
3
-2%
|
|
| Operating Income | ||||||||
| Operating Expenses |
(20)
|
(21)
|
(24)
|
(25)
|
(143)
|
(23)
|
(19)
|
|
| Selling, General & Administrative |
(10)
|
(10)
|
(11)
|
(12)
|
(12)
|
(11)
|
(10)
|
|
| Research & Development |
(9)
|
(11)
|
(13)
|
(13)
|
(13)
|
(12)
|
(9)
|
|
| Other Operating Expenses |
0
|
0
|
0
|
0
|
(117)
|
0
|
0
|
|
| Operating Income |
(19)
N/A
|
(21)
-7%
|
(24)
-17%
|
(25)
-3%
|
(142)
-472%
|
(20)
+86%
|
(16)
+22%
|
|
| Pre-Tax Income | ||||||||
| Interest Income Expense |
0
|
0
|
0
|
1
|
0
|
0
|
0
|
|
| Non-Reccuring Items |
0
|
(117)
|
(117)
|
(117)
|
0
|
0
|
0
|
|
| Total Other Income |
1
|
1
|
1
|
(25)
|
2
|
2
|
2
|
|
| Pre-Tax Income |
(18)
N/A
|
(137)
-655%
|
(141)
-3%
|
(167)
-18%
|
(140)
+16%
|
(18)
+87%
|
(13)
+25%
|
|
| Net Income | ||||||||
| Income from Continuing Operations |
(18)
|
(137)
|
(141)
|
(167)
|
(140)
|
(18)
|
(13)
|
|
| Net Income (Common) |
(18)
N/A
|
(137)
-655%
|
(141)
-3%
|
(55)
+61%
|
(35)
+37%
|
88
N/A
|
93
+6%
|
|
| EPS (Diluted) |
-21.56
N/A
|
-135.36
-528%
|
-146.65
-8%
|
-35.21
+76%
|
-4.78
+86%
|
15.11
N/A
|
10.59
-30%
|
|
Switch to:
Switch to:
See Also
Discover More
